HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Krauss, G. L. Articles by Summerfield, M. Search for Related Content PubMed PubMed Citation Articles by Krauss, G. L. Articles by Summerfield, M.

Antiepileptic medication and oral contraceptive interactions

A national survey of neurologists and obstetricians

From the Departments of Neurology (Dr. Krauss, Ms. Campbell, Ms. Plate, and Mr. Summerfield) and Psychiatry (Dr. Brandt); Johns Hopkins University, Baltimore, MD.
Received July 11, 1995. Accepted in final form October 2, 1995.
Address correspondence and reprint requests to Dr. Gregory L. Krauss, Johns Hopkins Hospital, Meyer 2-147, 600 N. Wolfe Street, Baltimore, MD 21287-7247.

Hepatic enzyme-inducing antiepileptic drugs (AEDs) lower oral contraceptive (OC) sex hormone levels approximately 40% and increase the risk of unplanned pregnancies in women with epilepsy. AEDs also increase the risk of birth defects in offspring of women with epilepsy. We performed a national survey to determine obstetricians' and neurologists' knowledge of OC and AED interactions and the risk of birth defects for women with epilepsy taking AEDs. We received responses to a mailed questionnaire from 160 of 1,000 neurologists (16%) and 147 of 1,000 obstetricians (15%) from 47 states. Practice demographics and ages of responders were typical for U.S. neurologists and obstetricians. Ninety-one percent of neurologists and 75% of obstetricians said they treat women with epilepsy of child-bearing age. Only 4% of the neurologists and none of the obstetricians, however, knew the effects of the six most common AEDs on OCs, even though 27% of neurologists and 21% of obstetricians reported OC failures in their patients taking AEDs. Although increasing OC doses can compensate for insufficient OC sex hormone levels due to AEDs, most physicians do not increase the doses. Even though the risk of birth defects for the offspring of women with epilepsy is 4 to 6%, up from the background level of 2%, 44% of neurologists thought the risk was lower (0 to 3%), and some of the respondents guessed that it was as high as 50%. Many neurologists and obstetricians do not have accurate information to counsel women with epilepsy properly about their contraceptive and pregnancy choices.

NEUROLOGY 1996;46: 1534-1539

This article has been cited by other articles:

				M. L. Zupanc Antiepileptic drugs and hormonal contraceptives in adolescent women with epilepsy Neurology, March 28, 2006; 66(66_suppl_3): S37 - S45. [Abstract] [Full Text]

				P. W. Kaplan Reproductive health effects and teratogenicity of antiepileptic drugs Neurology, November 23, 2004; 63(10_suppl_4): S13 - S23. [Abstract] [Full Text]

				W. O. Tatum IV, J. Liporace, S. R. Benbadis, and P. W. Kaplan Updates on the Treatment of Epilepsy in Women Arch Intern Med, January 26, 2004; 164(2): 137 - 145. [Abstract] [Full Text] [PDF]

				S. Wiebe Managing women with epilepsy BMJ, January 1, 2000; 320(7226): 3 - 4. [Full Text]

				Antiepileptics and Oral Contraceptives: A Reminder Journal Watch Psychiatry, August 1, 1996; 1996(801): 1 - 1. [Full Text]

				Antiepileptic Drugs and OCs: A Reminder Journal Watch Women's Health, August 1, 1996; 1996(801): 5 - 5. [Full Text]